Related Experiment Videos
Genetic heterogeneity and clonal evolution in neuroblastoma
J Mora1, N K Cheung, W L Gerald
1Departments of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. MoraJ@MSKCC.org
British Journal of Cancer
|July 20, 2001
Summary
Neuroblastoma (NB) tumors display significant genetic diversity, with distinct genetic patterns emerging over time and location. Chemotherapy can select for specific NB clones, altering tumor genetics during treatment.
Area of Science:
- Cancer Genetics
- Pediatric Oncology
- Tumor Biology
Background:
- Tumor heterogeneity and clonal evolution are implicated in neuroblastoma (NB) malignancy and treatment resistance.
- Understanding genetic changes within NB tumors is crucial for effective therapeutic strategies.
Purpose of the Study:
- To evaluate clonal heterogeneity and clonal selection in vivo in neuroblastoma (NB) using 1p allelic analysis and DNA ploidy.
- To investigate genetic alterations in NB tumors before and after chemotherapy.
Main Methods:
- Analyzed 69 NB tumors from 29 patients using 1p allelic markers and DNA ploidy.
- Studied tumor samples from different locations/times (Group 1) and paired samples before/after chemotherapy (Group 2).
- Utilized karyotype, FISH, and flow cytometry for DNA ploidy analysis.
Main Results:
- 66% of Group 1 samples showed heterogeneity, with distinct allelic patterns in spatially or temporally separated tumors.
- 60% of Group 2 samples exhibited altered allelic patterns post-chemotherapy.
- Pre-chemotherapy NB samples had both diploid and triploid clones; post-chemotherapy samples were uniformly diploid.
Conclusions:
- Neuroblastoma (NB) exhibits substantial clonal heterogeneity.
- Clonal evolution occurs during NB therapy and clinical progression, with chemotherapy potentially driving selection.
- Genetic diversity in NB impacts disease progression and treatment response.